CDKN2A expression was significantly up-regulated in ACC, CESC, AML, DLBC, OV, PAAD, PCPG, sarcoma, THYM, and UCS, whereas significantly down-regulated in TGCT. This evidence concerns the gene CDKN2A and acute myeloid leukemia.